Cardio3 to commence Phase III heart failure trial of C3BS-CQR-1 in Belgium Pharmaceutical Business Review Multi-centre, randomized trial designed to compare C3BS-CQR-1 treatment with sham treatment is expected to enroll at least 240 patients suffering from chronic advanced symptomatic heart failure. The composite endpoint of mortality, morbidity, quality ... |
